The defining characteristic of Companion Diagnostics (CDx) is that their use is associated with selection of a therapy or other medical intervention. This combination of test and treatment creates complications as both parts of any new regime need to be coordinated. At the same time there are great opportunities to improve healthcare outcomes when personalised medicine is implemented effectively. This talk will take a high-level view of healthcare systems and suggest strategies to ensure successful translation of a CDx into clinical practice.
Learning Objectives:
1. Recognize the development of the field of personalised medicine.
2. Describe the scientific, clinical and commercial forces influencing the translation of Companion Diagnostics into routine use.
3. Summarize perspectives on future developments in diagnostics and therapeutics which will further impact the field of personalised medicine.